10 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01161 | Antimicrobial peptide TsAP-1 | MQIKHLITLFFLVLIVADQCSAFLSLIPSLVGGSISAFKGRRKREISAQIEQYKDLQKREAELEELLDRLPMY | Brazilian scorpion | Membrane disruption | MTT Cell viability assay | NCIeH838 | Human Lung adenocarcinoma | IC50 : 0.83 - 2.0 μM |
| dbacp01165 | Antimicrobial peptide TsAP-1 | MQIKHLITLFFLVLIVADQCSAFLSLIPSLVGGSISAFKGRRKREISAQIEQYKDLQKREAELEELLDRLPMY | Brazilian scorpion | Antiproliferative action | Not specified | H838 | Prostate cancer | IC50 : 55.9 μM |
| dbacp01169 | Antimicrobial peptide TsAP-3 | MQIKHLITIFFLVLIVADHCHAFLGMIPGLIGGLISAFKGRRKREITSQIEQYRNLQKREAELENLLANLPVY | Brazilian scorpion | Antiproliferative activity | Not specified | H838 | Prostate cancer | IC50 : 11 μM |
| dbacp01433 | B1AW | FLPLLAGLAANFLPQIICKIARKC | Wuyi torrent frog | Cell membrane penetration | MTT assay | H838 | Non-small lung cancer | IC50 : 32.15 μM |
| dbacp01945 | Brevinin-1OS | FPLIASLAGNVVPKIFCKITKRC | Schmacker's frog | Not specified | Not specified | H838 | Lung | MIC : 10 μM |
| dbacp03519 | Kassiniatuerin-3 | FIQHLIPLIPHAIQGIKDIF | Senegal running frog, Africa | Membranolytic mechanism | MTT assay | NCI-H838 | Non-small cell Lung cancer | IC50 : 10.03 µM |
| dbacp05528 | Phylloseptin-PBa1 | FLSLIPHIASGIASLVKNF | Burmeister's leaf frog, Brazil, South America | Disruption of cell membranes | MTT cell viability assay | H838 | Lung cancer | IC50 : approx. 0.29 µM |
| dbacp05539 | Phylloseptin-PBa2 | FLSLLPHIASGIASLVSKF | Burmeister's leaf frog, Brazil, South America | Disruption of cell membranes | MTT cell viability assay | H838 | Lung cancer | IC50 : approx. 0.50 µM |
| dbacp06367 | TsAP-2 | FLGMIPGLIGGLISAFK | Venom, the Brazilian yellow scorpion, South America | Not specified | MTT/MTS assay | NCI-H838 | Human squamous carcinoma | IC50 : 11.0 µM |
| dbacp06375 | TsAP-S1 | FLSLIPKLVKKIIKAFK | The iNot foundctive natural peptide TsAP-1 was made active by increasing 4 lysines and one leucine, template-based design | Not specified | MTT/MTS assay | NCI-H838 | Human squamous carcinoma | IC50 : 52.5µM |